A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus (Q61306914)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus	article

Statements

scholarly article

0 references

A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus (English)

0 references

health professional

1 reference

based on heuristic

inferred from title

Caroline Sanders

object named as

Caroline Sanders

2

0 references

object named as

Rebecca Fish

1

0 references

David Sebag-Montefiore

9

object named as

David Sebag-Montefiore

0 references

Paula Williamson

10

object named as

Paula R Williamson

0 references

author name string

Richard Adams

3

0 references

Julie Brewer

4

0 references

Sara T Brookes

5

0 references

Jill DeNardo

6

0 references

Rohit Kochhar

7

0 references

Mark P Saunders

8

0 references

Andrew G Renehan

11

0 references

publication date

December 2018

0 references

full work available at URL

http://eprints.whiterose.ac.uk/139743

content deliverer

White Rose Research Online

object has role

7 May 2019

0 references

The lancet. Gastroenterology & hepatology

0 references

3

0 references

865-873

0 references

12

0 references

Combined therapy for cancer of the anal canal: a preliminary report. 1974.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined therapy for cancer of the anal canal

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical endpoints in trials of chemoradiation for patients with anal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The COMET Handbook: version 1.0.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC).

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Core outcome research measures in anal cancer (CORMAC): protocol for systematic review, qualitative interviews and Delphi survey to develop a core outcome set in anal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Core Outcome Set-STAndards for Reporting: The COS-STAR Statement

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A taxonomy has been developed for outcomes in medical research to help improve knowledge discovery.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

End points in anal cancer: hopes for a common language.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

When progressive disease does not mean treatment failure: reconsidering the criteria for progression

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression-free survival: meaningful or simply measurable?

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Core Outcome Set-STAndards for Development: The COS-STAD recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Core Outcomes for Colorectal Cancer Surgery: A Consensus Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a Core Outcome Set for Clinical Effectiveness Trials in Esophageal Cancer Resection Surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The Need for Adverse Effects Reporting Standards in Oncology Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reliability of adverse symptom event reporting by clinicians

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The missing voice of patients in drug-safety reporting

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

How to select outcome measurement instruments for outcomes included in a "Core Outcome Set" - a practical guideline

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2818%2930264-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2468-1253(18)30264-4

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61306914&oldid=1419609219"